Press Releases Edwards Lifesciences Corporation Wiener Boerse

Equities

EWLS

US28176E1082

End-of-day quote Wiener Boerse Other stock markets 23:00:00 07/05/2024 BST			5-day change	1st Jan Change
79.44 ^EUR	-0.23%		+0.43%	+14.50%

05-09	Edwards Lifesciences Corporation Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	CI
05-07	Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	05-09	BU
Edwards Lifesciences: Q1 Earnings Snapshot	04-25	AQ
Edwards Lifesciences Reports First Quarter Results	04-25	BU
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024	04-18	BU
Edwards Lifesciences - Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease without Knowing It	04-08	AQ
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It	04-07	BU
Precedential Federal Circuit Opinion Underscores Tension In Interpretation Of The Safe Harbor Of 35 U.S.C. § 271(e)(1)	04-03	AQ
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR	03-11	BU
EDWARDS LIFESCIENCES TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTHCARE CONFERENCE	02-26	AQ
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference	02-23	BU
Edwards Lifesciences: Q4 Earnings Snapshot	02-06	AQ
Edwards Lifesciences Reports Fourth Quarter Results	02-06	BU
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve	02-02	BU
Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024	01-30	BU
The Party Season Is Upon Us But What Does A Party Look Like To The Unified Patent Court?	01-02	AQ
Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference	01-02	BU
Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference	12-07	BU
CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION	26/10/23	PR
TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION	26/10/23	PR
Edwards Lifesciences: Q3 Earnings Snapshot	25/10/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 04:25 pm